Concur said it partnered with five pharma solution providers to support corporate compliance with provisions of the U.S. Affordable Care Act

that will require drug, biologic and medical device makers to track expenses related to marketing to physicians and teaching hospitals and report such expenses to a publicly accessible national database. Through Concur's Connect platform, corporations can upload and report expenses to and obtain provider data from AdvantageMS, Healthcare Data Solutions, MedPro Systems, Porzio Pharmaceutical Services and R-Squared. Under these terms of the federal law, also known as the Physician Payments Sunshine Act, such reporting was to begin in March 2013, but late last year that deadline was delayed. The U.S. Centers for Medicare and Medicaid Services last month closed a comment period on its proposed rule and is expected to release a final rule and reporting deadlines.